Searched for: Department/Unit:Cell Biology
GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans
Patel, Satish; Alvarez-Guaita, Anna; Melvin, Audrey; Rimmington, Debra; Dattilo, Alessia; Miedzybrodzka, Emily L; Cimino, Irene; Maurin, Anne-Catherine; Roberts, Geoffrey P; Meek, Claire L; Virtue, Samuel; Sparks, Lauren M; Parsons, Stephanie A; Redman, Leanne M; Bray, George A; Liou, Alice P; Woods, Rachel M; Parry, Sion A; Jeppesen, Per B; Kolnes, Anders J; Harding, Heather P; Ron, David; Vidal-Puig, Antonio; Reimann, Frank; Gribble, Fiona M; Hulston, Carl J; Farooqi, I Sadaf; Fafournoux, Pierre; Smith, Steven R; Jensen, Jorgen; Breen, Danna; Wu, Zhidan; Zhang, Bei B; Coll, Anthony P; Savage, David B; O'Rahilly, Stephen
GDF15 is an established biomarker of cellular stress. The fact that it signals via a specific hindbrain receptor, GFRAL, and that mice lacking GDF15 manifest diet-induced obesity suggest that GDF15 may play a physiological role in energy balance. We performed experiments in humans, mice, and cells to determine if and how nutritional perturbations modify GDF15 expression. Circulating GDF15 levels manifest very modest changes in response to moderate caloric surpluses or deficits in mice or humans, differentiating it from classical intestinally derived satiety hormones and leptin. However, GDF15 levels do increase following sustained high-fat feeding or dietary amino acid imbalance in mice. We demonstrate that GDF15 expression is regulated by the integrated stress response and is induced in selected tissues in mice in these settings. Finally, we show that pharmacological GDF15 administration to mice can trigger conditioned taste aversion, suggesting that GDF15 may induce an aversive response to nutritional stress.
PMID: 30639358
ISSN: 1932-7420
CID: 3682092
In Reply to the Letter to the Editor from Ramkisoensing: Young Versus Adult: Finding Clues to Unravel the Increased Regenerative Ability of Stem Cells from Young Donors [Letter]
Kosaric, Nina; Gurtner, Geoffrey C
PMID: 30761688
ISSN: 1549-4918
CID: 3685082
TGFβ blockade enhances radiotherapy abscopal efficacy effects in combination with anti-PD1 and anti-CD137 immunostimulatory monoclonal antibodies
Rodriguez-Ruiz, Maria E; Rodriguez, Inmaculada; Mayorga, Lina; Labiano, Tania; Barbes, Benigno; Etxeberria, Inaki; Ponz-Sarvise, Mariano; Azpilikueta, Arantza; Bolaños, Elixabet; Sanmamed, Miguel F; Berraondo, Pedro; Calvo, Felipe A; Barcellos-Hoff, Mary Helen; Perez-Gracia, Jose Luis; Melero, Ignacio
Radiotherapy can be synergistically combined with immunotherapy in mouse models, extending its efficacious effects outside of the irradiated field (abscopal effects). We previously reported that a regimen encompassing local radiotherapy in combination with anti-CD137 plus anti-PD-1 mAbs achieves potent abscopal effects against syngeneic transplanted murine tumors up to a certain tumor size. Knowing that TGF-beta expression or activation increases in irradiated tissues, we tested whether TGF-beta blockade may further enhance abscopal effects in conjunction with the anti-PD-1 plus anti-CD137 mAb combination. Indeed, TGFβ blockade with 1D11, a TGFβ neutralizing monoclonal antibody, markedly enhanced abscopal effects and overall treatment efficacy against subcutaneous tumors of either 4T1 breast cancer cells or large MC38 colorectal tumors. Increases in CD8 T cells infiltrating the non-irradiated lesion were documented upon combined treatment, which intensely expressed Granzyme-B as an indicator of cytotoxic effector capability. Interestingly, tumor tissue but not healthy tissue irradiation results in the presence of higher concentrations of TGFβ in the non-irradiated contralateral tumor which showed smad2/3 phosphorylation increases in infiltrating CD8 T cells. In conclusion, radiotherapy-induced TGF-beta hampers abscopal efficacy even upon combination with a potent immunotherapy regimen. Therefore TGF-beta blockade in combination with radioimmunotherapy results in greater efficacy.
PMID: 30683810
ISSN: 1538-8514
CID: 3683262
Genetic deletion of genes in the cerebellar rhombic lip lineage can stimulate compensation through adaptive reprogramming of ventricular zone-derived progenitors
Wojcinski, Alexandre; Morabito, Morgane; Lawton, Andrew K; Stephen, Daniel N; Joyner, Alexandra L
BACKGROUND:The cerebellum is a foliated posterior brain structure involved in coordination of motor movements and cognition. The cerebellum undergoes rapid growth postnataly due to Sonic Hedgehog (SHH) signaling-dependent proliferation of ATOH1+ granule cell precursors (GCPs) in the external granule cell layer (EGL), a key step for generating cerebellar foliation and the correct number of granule cells. Due to its late development, the cerebellum is particularly vulnerable to injury from preterm birth and stress around birth. We recently uncovered an intrinsic capacity of the developing cerebellum to replenish ablated GCPs via adaptive reprogramming of Nestin-expressing progenitors (NEPs). However, whether this compensation mechanism occurs in mouse mutants affecting the developing cerebellum and could lead to mis-interpretation of phenotypes was not known. METHODS:We used two different approaches to remove the main SHH signaling activator GLI2 in GCPs: 1) Our mosaic mutant analysis with spatial and temporal control of recombination (MASTR) technique to delete Gli2 in a small subset of GCPs; 2) An Atoh1-Cre transgene to delete Gli2 in most of the EGL. Genetic Inducible Fate Mapping (GIFM) and live imaging were used to analyze the behavior of NEPs after Gli2 deletion. RESULTS:Mosaic analysis demonstrated that SHH-GLI2 signaling is critical for generating the correct pool of granule cells by maintaining GCPs in an undifferentiated proliferative state and promoting their survival. Despite this, inactivation of GLI2 in a large proportion of GCPs in the embryo did not lead to the expected dramatic reduction in the size of the adult cerebellum. GIFM uncovered that NEPs do indeed replenish GCPs in Gli2 conditional mutants, and then expand and partially restore the production of granule cells. Furthermore, the SHH signaling-dependent NEP compensation requires Gli2, demonstrating that the activator side of the pathway is involved. CONCLUSION/CONCLUSIONS:We demonstrate that a mouse conditional mutation that results in loss of SHH signaling in GCPs is not sufficient to induce long term severe cerebellum hypoplasia. The ability of the neonatal cerebellum to regenerate after loss of cells via a response by NEPs must therefore be considered when interpreting the phenotypes of Atoh1-Cre conditional mutants affecting GCPs.
PMID: 30764875
ISSN: 1749-8104
CID: 3685162
Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety
Rappo, Urania; Puttagunta, Sailaja; Shevchenko, Vadym; Shevchenko, Alena; Jandourek, Alena; Gonzalez, Pedro L; Suen, Amy; Mas Casullo, Veronica; Melnick, David; Miceli, Rosa; Kovacevic, Milan; De Bock, Gertjan; Dunne, Michael W
Background/UNASSIGNED:Osteomyelitis is a challenging infection that can involve 4-6 weeks of intravenous (IV) antibiotics. Dalbavancin, approved for acute bacterial skin and skin structure infections, has potent activity against gram-positive pathogens. This study assessed the efficacy and safety of dalbavancin as a 2-dose regimen for osteomyelitis. Methods/UNASSIGNED:This study was a randomized, open-label, comparator-controlled trial in adults with a first episode of osteomyelitis defined by clinical symptoms, radiologic findings, and elevated C-reactive protein. Patients were randomized 7:1 to dalbavancin (1500 mg IV on days 1 and 8) or standard of care (SOC) for osteomyelitis (oral or IV) per investigator judgment for 4-6 weeks. The primary endpoint was clinical response at day 42, defined as recovery without need for additional antibiotics in the clinically evaluable (CE) population. Clinical response was also assessed at day 21, 6 months, and 1 year. Results/UNASSIGNED:was the most common pathogen (60% of patients). Clinical cure at day 42 was seen in 65/67 (97%) and 7/8 (88%) patients in the dalbavancin group and SOC group in the CE population, respectively. Clinical response was similar in the dalbavancin group at day 21 (94%), 6 months, and 1 year (96%). Treatment-emergent adverse events occurred in 10 patients in the dalbavancin group; no patient discontinued treatment due to an adverse event. Conclusions/UNASSIGNED:A 2-dose regimen of weekly dalbavancin is effective and well tolerated for the treatment of osteomyelitis in adults. Clinical Trials Registration/UNASSIGNED:NCT02685033.
PMCID:6326511
PMID: 30648126
ISSN: 2328-8957
CID: 3682292
Individual long non-coding RNAs have no overt functions in zebrafish embryogenesis, viability and fertility
Goudarzi, Mehdi; Berg, Kathryn; Pieper, Lindsey M; Schier, Alexander F
Hundreds of long non-coding RNAs (lncRNAs) have been identified as potential regulators of gene expression, but their functions remain largely unknown. To study the role of lncRNAs during vertebrate development, we selected 25 zebrafish lncRNAs based on their conservation, expression profile or proximity to developmental regulators, and used CRISPR-Cas9 to generate 32 deletion alleles. We observed altered transcription of neighboring genes in some mutants, but none of the lncRNAs were required for embryogenesis, viability or fertility. Even RNAs with previously proposed non-coding functions (cyrano and squint) and other conserved lncRNAs (gas5 and lnc-setd1ba) were dispensable. In one case (lnc-phox2bb), absence of putative DNA regulatory-elements, but not of the lncRNA transcript itself, resulted in abnormal development. LncRNAs might have redundant, subtle, or context-dependent roles, but extrapolation from our results suggests that the majority of individual zebrafish lncRNAs have no overt roles in embryogenesis, viability and fertility.
PMCID:6347452
PMID: 30620332
ISSN: 2050-084x
CID: 3681512
Traumatic experiences and cognitive profiles of schizophrenia cases influenced by the BDNF Val66met polymorphism
Veras, André B; Chao, Moses V; Getz, Mara; Goetz, Raymond; Cheniaux, Elie; Lopes, Fabiana L; Nardi, Antonio E; Walsh-Messinger, Julie; Malaspina, Dolores; Kranz, Thorsten M
The association of early trauma exposure with current cognition was examined in a research series of 56 schizophrenia cases with respect to the BDNF Val66Met polymorphism (rs6265, Val66Val, Val66Met, Met66Met), as met allele carriers have reduced neurotrophic activity. The Perceptual Organization Index had a significant negative correlation with trauma exposures only in met carriers, including early physical abuse, general trauma after age 18 years, and physical abuse. Within the Val66Val subgroup, there were no significant correlations between WAIS indices and traumatic experiences.
PMID: 30472504
ISSN: 1872-7123
CID: 3677382
Wound Healing: A Cellular Perspective
Rodrigues, Melanie; Kosaric, Nina; Bonham, Clark A; Gurtner, Geoffrey C
Wound healing is one of the most complex processes in the human body. It involves the spatial and temporal synchronization of a variety of cell types with distinct roles in the phases of hemostasis, inflammation, growth, re-epithelialization, and remodeling. With the evolution of single cell technologies, it has been possible to uncover phenotypic and functional heterogeneity within several of these cell types. There have also been discoveries of rare, stem cell subsets within the skin, which are unipotent in the uninjured state, but become multipotent following skin injury. Unraveling the roles of each of these cell types and their interactions with each other is important in understanding the mechanisms of normal wound closure. Changes in the microenvironment including alterations in mechanical forces, oxygen levels, chemokines, extracellular matrix and growth factor synthesis directly impact cellular recruitment and activation, leading to impaired states of wound healing. Single cell technologies can be used to decipher these cellular alterations in diseased states such as in chronic wounds and hypertrophic scarring so that effective therapeutic solutions for healing wounds can be developed.
PMID: 30475656
ISSN: 1522-1210
CID: 3677462
Japan Obstetric Compensation System for Cerebral Palsy: Strategic system of data aggregation, investigation, amelioration and no-fault compensation
Ushiro, Shin; Suzuki, Hideaki; Ueda, Shigeru
The Japan Obstetric Compensation System for Cerebral Palsy (JOCS-CP), which investigates, develops preventive mechanisms and awards monetary compensation, to cases of cerebral palsy was urgently introduced in 2009 in response to growing concern about Japan's deteriorating perinatal care and low birthrate. Under the political leadership, the Japan Council for Quality Health Care launched the JOCS-CP with support of various stakeholders. The JOCS-CP features of no-fault-based compensation which was discussed decades ago in the Japan Medical Association aiming at financial aid to patient and family and early settlement of dispute. As of 2017, 2233 petitions had been approved by the Review Committee for compensation. All the approved cases were consecutively put on analysis in the Investigation Committee which has compiled more than 1000 Investigative Reports. The reports were delivered not only to the childbirth facility but to the guardians/families. Survey revealed that most of childbirth facility and the guardians/families responded in favor of the reports. With regard to amelioration of profound cerebral palsy, the Prevention Report has been published on annual basis through analysis of all the Investigative Reports. The Prevention Reports and other educational materials were produced and distributed not only among medical professionals but among pregnant women. It is notable that the number of lawsuit filing related to obstetrics demonstrated rapid decrease compared to that of other medical specialties. The JOCS-CP could be described as a social experiment. It was overhauled in 2015 but deserves further discussion on reform for evolving into better system.
PMID: 30672080
ISSN: 1447-0756
CID: 3682912
Population-neuroscience study of the Tokyo TEEN Cohort (pn-TTC): Cohort longitudinal study to explore the neurobiological substrates of adolescent psychological and behavioral development
Okada, Naohiro; Ando, Shuntaro; Sanada, Motoyuki; Hirata-Mogi, Sachiko; Iijima, Yudai; Sugiyama, Hiroshi; Shirakawa, Toru; Yamagishi, Mika; Kanehara, Akiko; Morita, Masaya; Yagi, Tomoko; Hayashi, Noriyuki; Koshiyama, Daisuke; Morita, Kentaro; Sawada, Kingo; Ikegame, Tempei; Sugimoto, Noriko; Toriyama, Rie; Masaoka, Mio; Fujikawa, Shinya; Kanata, Sho; Tada, Mariko; Kirihara, Kenji; Yahata, Noriaki; Araki, Tsuyoshi; Jinde, Seiichiro; Kano, Yukiko; Koike, Shinsuke; Endo, Kaori; Yamasaki, Syudo; Nishida, Atsushi; Hiraiwa-Hasegawa, Mariko; Bundo, Miki; Iwamoto, Kazuya; Tanaka, Saori C; Kasai, Kiyoto
AIM/OBJECTIVE:Adolescence is a crucial stage of psychological development and is critically vulnerable to the onset of psychopathology. Our understanding of how the maturation of endocrine, epigenetics, and brain circuit may underlie psychological development in adolescence, however, has not been integrated. Here, we introduce our research project, the population-neuroscience study of the Tokyo TEEN Cohort (pn-TTC), a longitudinal study to explore the neurobiological substrates of development during adolescence. METHODS:Participants in the first wave of the pn-TTC (pn-TTC-1) study were recruited from those of the TTC study, a large-scale epidemiological survey in which 3171 parent-adolescent pairs were recruited from the general population. Participants underwent psychological, cognitive, sociological, and physical assessment. Moreover, adolescents and their parents underwent magnetic resonance imaging (MRI; structural MRI, resting-state functional MRI, and magnetic resonance spectroscopy), and adolescents provided saliva samples for hormone analysis and for DNA analysis including epigenetics. Furthermore, the second wave (pn-TTC-2) followed similar methods as in the first wave. RESULTS:A total of 301 parent-adolescent pairs participated in the pn-TTC-1 study. Moreover, 281 adolescents participated in the pn-TTC-2 study, 238 of whom were recruited from the pn-TTC-1 sample. The instruction for data request is available at: http://value.umin.jp/data-resource.html. CONCLUSION/CONCLUSIONS:The pn-TTC project is a large-scale and population-neuroscience-based survey with a plan of longitudinal biennial follow up. Through this approach we seek to elucidate adolescent developmental mechanisms according to biopsychosocial models. This current biomarker research project, using minimally biased samples recruited from the general population, has the potential to expand the new research field of population neuroscience.
PMID: 30588712
ISSN: 1440-1819
CID: 3680562